| http://www.w3.org/ns/prov#value | - In some embodiments, the tissue sample is a post-surgical prostate tumor tissue sample and the method further comprises the step of identifying a risk of prostate specific antigen failure based on detecting the presence or absence of CD97 and/or CD55.
|
